Issue Date | Title | Author(s) |
2023 | Analysis of community pharmacists work patterns | Caruana, Sophie (2023) |
2023 | Statin associated muscle symptoms and therapy adherence | Calleja, Jean Claude (2023) |
2023 | Drug information sources for community pharmacy practice | Farrugia, Luca (2023) |
2023 | Developing a framework for inappropriate prescribing in a community pharmacy setting : a risk-based approach | Galea Salomone, Philippa (2023) |
2023 | Meeting challenges in achieving and maintaining ISO standards | Portelli, Timothy (2023) |
2023 | Design, identification and validation of toll-like receptor 8 (TLR8) modulators using the Cu-CPT8m scaffold as a lead | Zammit, Tiffany (2023) |
2023 | Pharmacist interventions when responding to symptoms | Cassar, Miriana (2023) |
2023 | Proposal for setting up a forensic toxicology laboratory | Grima, Kimberly (2023) |
2023 | Designation and oversight of notified bodies in medical device regulatory sciences | Farrugia, Karen (2023) |
2023 | Community pharmacist-led falls risk evaluation | Omandac, John Robert Diong (2023) |
2023 | Risks in medical device vigilance | Almojero, Danielle Claire E. (2023) |
2023 | Digitalisation of regulatory activities for medical devices | Ignas, Louella Bianca (2023) |
2023 | Risks in pharmacy practice research | Amar, Jaycerie Joy Y. (2023) |
2023 | Constituents of cannabidiol products | Gallo, Lovely Lynne (2023) |
2023 | Antimicrobial stewardship : a priority for clinical pharmacists | Gatt, David (2023) |
2023 | Feasibility of an official medicines control laboratory | Gatt Baldacchino, Elaine (2023) |
2023 | Validation of self-assessment of community pharmacy services | Cilia, Francesca (2023) |
2023 | Harm from vaccines : science, myth or reality | Chen, Hei Ying (2023) |
2023 | Risk of deviations in pharmaceutical processes | Camilleri, Leanne (2023) |
2023 | Pharmacovigilance obligations in the pharmaceutical industry | Suwan, Alaa M M (2023) |
Collection's Items (Sorted by Submit Date in Descending order): 21 to 40 of 47